NPY signalling on the ECs thus appears to be vasodilatory, suggesting that in patients with low NO bioavailability and damaged endothelium, common hallmarks of cardiovascular diseases, circulating NPY could be more vasoactive, contributing to hypertension and reduction in coronary blood flow. Here, NPY is linked to Hypertension.